Targeting Treatment-Resistant Cancer.
resistanceBio has built the first cancer treatment resistance system to predict how multiple cancer types will respond to approved or novel treatments. The ResCu platform aims only to advance therapies that have the potential to be superior to the standard of care and significantly extend patients’ lives. ResCu addresses the root cause of treatment failure, which is treatment resistance.
ResCu may dramatically increase the number of approved novel therapies for cancer patients by determining:
Why us? Why now?
We aren’t just treatment resistance experts. We are devoting our lives to helping cancer patients defeat treatment-resistant cancer.
Join us in learning more about our mission to defeat treatment-resistant cancer.